Abstract
Information regarding the value of chemotherapy for spinal cord astrocytomas that progress after irradiation is limited. We describe a patient whose conus medullaris astrocytoma responded to PCV (procarbazine, lomustine, and vincristine) chemotherapy after failing radiation and cisplatin-based chemotherapy. PCV should be considered in patients with progressive spinal cord astrocytomas.
Original language | English (US) |
---|---|
Pages (from-to) | 518-520 |
Number of pages | 3 |
Journal | Neurology |
Volume | 54 |
Issue number | 2 |
DOIs | |
State | Published - Jan 25 2000 |
Externally published | Yes |
Keywords
- Astrocytoma
- Chemotherapy
- Spinal neoplasm
ASJC Scopus subject areas
- Clinical Neurology